Newborn Sickle Cell Disease Screening System in Uganda
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a new computer system to help hospitals quickly identify babies with sickle cell disease (an inherited blood disorder) right after birth or at early health visits. Finding sickle cell disease early helps prevent serious health problems and saves lives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at or regularly attends one of the participating hospitals in Uganda
- Your baby is an infant (newborn to early childhood age)
- You are willing and able to provide informed consent for your baby to participate
- Your baby has not already been formally diagnosed with sickle cell disease before enrollment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples from up to 1 million people in Uganda to learn more about sickle cell disease. It helps doctors understand how common it is and how to better care for those affected.
This study tests a new way to screen babies for sickle cell disease at the point of care. It aims to make screening faster and easier for families and health workers.
This study is testing a new way to screen all newborns for sickle cell disease in Mozambique. It aims to find babies with the condition early so they can get the right care from the start.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study is developing a risk assessment tool to help predict complications in pregnant women with sickle cell disease. It reviews medical records from women who have received prenatal care and given birth at participating hospitals.
This study helps connect adults with sickle cell disease who haven't seen a specialist in over a year back into care. It tests a program designed to make it easier to get regular medical support and improve your health.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.